On June 4, 2020 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases including solid tumors, hematologic cancers and autoimmune disease, reported that Pascal Touchon, the Company’s President and Chief Executive Officer, will participate at two upcoming virtual conferences in June (Press release, Atara Biotherapeutics, JUN 4, 2020, View Source [SID1234560880]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Goldman Sachs 41st Annual Global Healthcare Conference
Video Fireside Chat: Thursday, June 11, 2020 at 3:50 p.m. EDT

A live video webcast of the Goldman Sachs presentation will be available by visiting the Investor Events and Presentations section of atarabio.com. An archived replay will be available on the Company’s website for approximately 14 days following the live webcast.

BIO Digital
Company Presentation: available on-demand via the BIO website, June 8-12, 2020